Nicotinic receptors ibogaine

Badio B, Padgett WL, Daly JW. (1997). Ibogaine a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors. Mol Pharmacol. 51(1) 1-5. 

Schneider AS, Nagel JE, Mah SJ. (1996). Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release. Eur J Pharmacol. 317(2-3) Rl-2. 

Although controlling ion channels is the best-known function of the nicotinic receptor, there are examples of other processes under control of this receptor. There is one, for instance, that mediates the release of dopamine or other catecholamines and is inhibited by ibogaine or strychnine [163, 164, 165]. 

Fryer JD, Lukas RJ. (1999). Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther. 288(1) 88-92. 

Mah SJ, Tang Y, Liauw PE, Nagei JE, Schneider AS. (1998). Ibogaine acts at the nicotinic acetyichoiine receptor to inhibit catechoiamine reiease. Brain Res. 797(1) 173-80. 

---